Current Affairs

General Studies Prelims

General Studies (Mains)

Antibiotic Resistance Crisis and Regulatory Challenges

Antibiotic Resistance Crisis and Regulatory Challenges

Antibiotic resistance is becoming a critical public health issue. Experts warn that overuse of powerful antibiotics is leading to diminished effectiveness. The Drugs Controller General of India (DCGI) faces pressure to establish stringent regulations to prevent misuse. Ceftazidime-avibactam, a potent last-line antibiotic, is a prime example of this crisis. Initially approved in the U.S. in 2015 and in India in 2018, it is intended for specific infections caused by carbapenem-resistant bacteria. However, its misuse in the community is alarming.

About Antibiotic Resistance

Antibiotic resistance occurs when bacteria evolve to resist the effects of medications. This makes infections harder to treat. The misuse of antibiotics accelerates this process. Over-prescribing and inappropriate use in non-bacterial infections contribute to resistance. The emergence of resistant strains poses a severe risk to public health.

The Role of Ceftazidime-Avibactam

Ceftazidime-avibactam is a combination antibiotic designed to combat resistant gram-negative infections. It is crucial for treating infections where other antibiotics fail. However, experts like Dr. Abdul Ghafur warn that its efficacy is declining due to irrational use. The addition of aztreonam to this combination has also led to resistance, further complicating treatment options.

Regulatory Framework and Challenges

The DCGI has licensed ceftazidime-avibactam but has not established clear guidelines for its use. This lack of a regulatory framework allows for mis-prescription. Experts argue that without defined pathways, the potential for misuse will continue to jeopardise treatment outcomes. The recent ban on colistin in poultry was step forward, but more measures are needed to sustain progress against antibiotic resistance.

Future Antibiotics and Stewardship

Two new antibiotics, Cefiderocol and Cefepime-zidebactam, are set to enter the Indian market. Their introduction presents an opportunity to enhance treatment options. However, experts stress the importance of antibiotic stewardship. Strict guidelines must be enforced to ensure these drugs are used only when absolutely necessary. Education alone is insufficient; regulatory action is vital to safeguard these new therapies.

The Urgency of Action

Antimicrobial resistance is already a pressing crisis in India. Experts warn that without swift and decisive action, the situation may worsen. The gains made in reducing colistin-resistant bacteria could be eroded if current trends continue. The call for immediate regulatory measures is essential to preserve the efficacy of existing and future antibiotics.

Questions for UPSC:

  1. What are the implications of antibiotic resistance on global public health? Discuss in the light of current trends.
  2. Critically examine the role of regulatory bodies in managing antibiotic use in India. What measures can be implemented?
  3. Explain the significance of antibiotic stewardship in combating antimicrobial resistance.
  4. What is the impact of agricultural practices on the emergence of antibiotic-resistant bacteria? Discuss with suitable examples.

Answer Hints:

1. What are the implications of antibiotic resistance on global public health? Discuss in the light of current trends.
  1. Antibiotic resistance leads to higher mortality rates due to untreatable infections.
  2. It increases healthcare costs due to longer hospital stays and more complex treatments.
  3. Global trade and travel facilitate the spread of resistant bacteria across borders.
  4. Resistance undermines advancements in modern medicine, including surgeries and cancer treatments.
  5. Current trends show a rise in resistant infections, prompting urgent action from health organizations.
2. Critically examine the role of regulatory bodies in managing antibiotic use in India. What measures can be implemented?
  1. Regulatory bodies like the DCGI are responsible for licensing antibiotics and establishing usage guidelines.
  2. Current lack of clear pathways for antibiotic use allows for misuse and over-prescription.
  3. Implementing strict regulations on antibiotic sales and prescriptions can mitigate misuse.
  4. Regular monitoring and reporting of antibiotic resistance patterns can inform policy adjustments.
  5. Education and training for healthcare providers on appropriate antibiotic use is essential.
3. Explain the significance of antibiotic stewardship in combating antimicrobial resistance.
  1. Antibiotic stewardship promotes the appropriate use of antibiotics to reduce resistance development.
  2. It involves guidelines for prescribing antibiotics only when necessary and effective.
  3. Stewardship programs can help optimize patient outcomes and minimize adverse effects.
  4. They encourage ongoing education for healthcare professionals about resistance issues.
  5. Effective stewardship requires collaboration among healthcare providers, patients, and regulatory bodies.
4. What is the impact of agricultural practices on the emergence of antibiotic-resistant bacteria? Discuss with suitable examples.
  1. Overuse of antibiotics in livestock for growth promotion contributes to resistance in bacteria.
  2. Runoff from farms can contaminate water sources, spreading resistant bacteria to humans.
  3. Examples include the ban on colistin in poultry, which led to a decrease in resistance rates.
  4. Antibiotic use in agriculture can lead to the emergence of multi-drug resistant strains.
  5. Regulations on antibiotic use in farming are necessary to protect public health.

Leave a Reply

Your email address will not be published. Required fields are marked *

Archives